Clinical Trial Update: Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Triumeq as an integrase single-tablet regimen for people with HIV who inject drugs was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Triumeq (dolutegravir/abacavir/lamivudine)

Snippet

Sponsor: University College Dublin | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: TERMINATED